Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 91.13 -1.58% -1.46
AXSM closed down 1.58 percent on Friday, February 21, 2020, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Mar 12
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical AXSM trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Three Weeks Tight Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Support Bullish -1.58%
Bollinger Band Squeeze Range Contraction -1.58%
Multiple of Ten Bullish Other -1.58%
BB Squeeze Started Range Contraction -1.58%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Medicine Pain Organ Systems Alzheimer's Disease Pain Management Osteoarthritis Chronic Pain Central Nervous System Disorders Perception Antidepressants Back Pain Chronic Condition Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 109.94
52 Week Low 7.64
Average Volume 1,237,295
200-Day Moving Average 41.31
50-Day Moving Average 88.68
20-Day Moving Average 90.68
10-Day Moving Average 91.28
Average True Range 4.69
ADX 19.36
+DI 18.96
-DI 14.12
Chandelier Exit (Long, 3 ATRs ) 84.39
Chandelier Exit (Short, 3 ATRs ) 94.14
Upper Bollinger Band 96.17
Lower Bollinger Band 85.19
Percent B (%b) 0.54
BandWidth 12.11
MACD Line 1.58
MACD Signal Line 2.07
MACD Histogram -0.4863
Fundamentals Value
Market Cap 2.15 Billion
Num Shares 23.6 Million
EPS -1.45
Price-to-Earnings (P/E) Ratio -62.85
Price-to-Sales 0.00
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.72
Resistance 3 (R3) 94.74 93.56 94.12
Resistance 2 (R2) 93.56 92.65 93.55 93.92
Resistance 1 (R1) 92.35 92.09 91.76 92.33 93.72
Pivot Point 91.17 91.17 90.88 91.16 91.17
Support 1 (S1) 89.96 90.26 89.37 89.94 88.54
Support 2 (S2) 88.78 89.70 88.77 88.34
Support 3 (S3) 87.57 88.78 88.14
Support 4 (S4) 87.55